Taurus Asset Management LLC Sells 1,000 Shares of Becton Dickinson and Co (BDX)

Taurus Asset Management LLC cut its holdings in Becton Dickinson and Co (NYSE:BDX) by 1.1% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 86,405 shares of the medical instruments supplier’s stock after selling 1,000 shares during the quarter. Becton Dickinson and makes up about 2.6% of Taurus Asset Management LLC’s holdings, making the stock its 9th biggest holding. Taurus Asset Management LLC’s holdings in Becton Dickinson and were worth $16,931,000 at the end of the most recent quarter.

Other large investors have also added to or reduced their stakes in the company. Vanguard Group Inc. boosted its holdings in shares of Becton Dickinson and by 8.5% during the 2nd quarter. Vanguard Group Inc. now owns 17,255,948 shares of the medical instruments supplier’s stock valued at $3,366,809,000 after acquiring an additional 1,353,780 shares during the last quarter. State Street Corp boosted its holdings in shares of Becton Dickinson and by 3.5% during the 2nd quarter. State Street Corp now owns 10,270,221 shares of the medical instruments supplier’s stock valued at $2,003,834,000 after acquiring an additional 342,873 shares during the last quarter. Northern Trust Corp lifted its stake in shares of Becton Dickinson and by 4.0% in the 2nd quarter. Northern Trust Corp now owns 2,813,937 shares of the medical instruments supplier’s stock worth $549,028,000 after purchasing an additional 106,966 shares during the period. Fiera Capital Corp lifted its stake in shares of Becton Dickinson and by 7.1% in the 2nd quarter. Fiera Capital Corp now owns 2,782,146 shares of the medical instruments supplier’s stock worth $542,825,000 after purchasing an additional 183,372 shares during the period. Finally, Fundsmith LLP lifted its stake in shares of Becton Dickinson and by 0.3% in the 2nd quarter. Fundsmith LLP now owns 2,302,590 shares of the medical instruments supplier’s stock worth $449,258,000 after purchasing an additional 5,977 shares during the period. 87.72% of the stock is currently owned by hedge funds and other institutional investors.

Becton Dickinson and Co (NYSE BDX) traded down $0.26 during trading hours on Friday, hitting $214.06. The stock had a trading volume of 1,649,421 shares, compared to its average volume of 1,168,412. Becton Dickinson and Co has a fifty-two week low of $161.50 and a fifty-two week high of $229.68. The company has a market capitalization of $49,166.68, a P/E ratio of 46.03, a price-to-earnings-growth ratio of 1.68 and a beta of 1.07. The company has a debt-to-equity ratio of 1.44, a quick ratio of 5.03 and a current ratio of 5.58.

Becton Dickinson and (NYSE:BDX) last released its earnings results on Thursday, November 2nd. The medical instruments supplier reported $2.40 earnings per share for the quarter, topping the consensus estimate of $2.37 by $0.03. The business had revenue of $3.17 billion during the quarter, compared to the consensus estimate of $3.14 billion. Becton Dickinson and had a return on equity of 20.56% and a net margin of 8.52%. The business’s revenue for the quarter was down 2.0% compared to the same quarter last year. During the same period last year, the company earned $2.12 earnings per share. analysts forecast that Becton Dickinson and Co will post 10.64 EPS for the current fiscal year.

The company also recently disclosed a quarterly dividend, which was paid on Friday, December 29th. Investors of record on Friday, December 8th were issued a $0.75 dividend. This is an increase from Becton Dickinson and’s previous quarterly dividend of $0.73. This represents a $3.00 annualized dividend and a dividend yield of 1.40%. The ex-dividend date of this dividend was Thursday, December 7th. Becton Dickinson and’s payout ratio is presently 64.52%.

Several brokerages have recently weighed in on BDX. Deutsche Bank set a $260.00 price objective on shares of Becton Dickinson and and gave the stock a “buy” rating in a research note on Friday. Argus raised their target price on shares of Becton Dickinson and to $235.00 and gave the stock a “buy” rating in a research note on Thursday, December 14th. They noted that the move was a valuation call. Stifel Nicolaus restated a “buy” rating and set a $245.00 target price on shares of Becton Dickinson and in a research note on Friday, November 3rd. Morgan Stanley increased their price objective on shares of Becton Dickinson and from $205.00 to $245.00 and gave the company an “equal weight” rating in a report on Friday, November 3rd. Finally, Royal Bank of Canada reaffirmed a “sector perform” rating and set a $230.00 price objective (up from $210.00) on shares of Becton Dickinson and in a report on Friday, November 3rd. Four research analysts have rated the stock with a hold rating, twelve have assigned a buy rating and one has given a strong buy rating to the company’s stock. The stock presently has a consensus rating of “Buy” and a consensus price target of $221.13.

ILLEGAL ACTIVITY NOTICE: “Taurus Asset Management LLC Sells 1,000 Shares of Becton Dickinson and Co (BDX)” was first posted by Week Herald and is the property of of Week Herald. If you are reading this report on another domain, it was illegally stolen and reposted in violation of U.S. and international trademark & copyright laws. The original version of this report can be read at https://weekherald.com/2017/12/30/becton-dickinson-and-company-bdx-shares-sold-by-taurus-asset-management-llc.html.

Becton Dickinson and Profile

Becton, Dickinson and Company (BD) is a global medical technology company engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products. The Company operates through two segments: BD Medical and BD Life Sciences. The BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings.

Institutional Ownership by Quarter for Becton Dickinson and (NYSE:BDX)

Receive News & Ratings for Becton Dickinson and Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Becton Dickinson and and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply